Astera Labs, Inc. (ALAB) has a beneficial holder, Casa Alameda 2007, LLC, that submitted a notice under Rule 144 covering a potential sale of up to 33,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $9,800,340 and a proposed sale date of September 1, 2026 on Nasdaq.
The 33,000 shares were originally acquired on November 30, 2018 in a private acquisition from the issuer or an affiliate for cash. The notice also lists prior Rule 10b5-1 plan sales during the past three months by related trusts and entities holding Astera Labs common stock.
Astera Labs, Inc. (ALAB) reported that President and COO Gajendra Sanjay sold an aggregate 90,630 shares of Common Stock on August 17, 2026. The company states these shares were sold automatically under a pre-established “sell to cover” arrangement to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units, and that the transactions did not represent discretionary trades by the executive.
Weighted-average sale prices for the blocks ranged from about $333.60 to $352.11 per share, each over narrower intraday price ranges described in the footnotes. In addition, indirect holdings reported for estate-planning vehicles included 5,290,402 shares held by Trust 1, and 615,000 shares each held by Trust 2 and Trust 3, for which Sanjay disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. (ALAB) reported that its General Counsel and Secretary, Philip Mazzara, had multiple sales of common stock on August 17, 2026. In total, 6,801 shares were sold in open-market block trades at reported per-share prices between $333.6377 and $352.1027.
According to the company’s disclosure, these shares were sold to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units. The company states the sales were automatic under a pre-established “sell to cover” election made by Astera Labs and did not represent discretionary trading by Mazzara.
Astera Labs, Inc. (ALAB) reported that Chief Executive Officer and director Jitendra Mohan executed multiple sales of the company’s Common Stock on August 17, 2026. In total, 90,630 shares were sold in a series of open-market block trades at weighted-average prices generally between the mid-$330s and mid-$350s per share. According to the disclosure, these shares were required to be sold to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units, under an advance “sell to cover” election made by Astera Labs; the filing states these were not discretionary trades by Mohan. The filing also lists significant indirect holdings in various estate-planning and living trusts, including positions such as 699,999 shares held by an estate planning trust and 3,789,232 shares held by a living trust, for which Mohan disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. director Stefan A. Dyckerhoff reported sales of 12,499 shares of common stock on 2026-08-06. The shares were sold in multiple open-market transactions at weighted average prices around $309–$313 per share, pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025. Some shares were held directly, while others were held through trusts and a limited partnership for which he serves as trustee or through related roles, and he disclaims beneficial ownership beyond his pecuniary interest.
ALAB shareholder Stefan A. Dyckerhoff filed a notice to sell common stock through broker Stifel Nicolaus & Company Inc. The planned sale covers 12,499 shares of common stock with an aggregate market value of $3,897,584.00. The filing cites approximately 171,410,000 shares outstanding as of August 6, 2026. The shares were originally acquired via pro-rata distributions from Sutter Hill Ventures A CA LP and through private placements with the issuer. The filing also lists past sales of 12,499 shares on June 3, 2026 for $4,553,995.00 and 12,499 shares on July 1, 2026 for $5,624,555.00.
Astera Labs, a semiconductor company focused on cloud and AI connectivity, reported rapid year-over-year growth in Q2 2026. Revenue was $392.4 million, up 104% from Q2 2025, and first-half revenue reached $700.8 million, up 99%. GAAP gross margin remained high at 73.3%, though down 250 basis points from a year earlier due to a greater mix of lower-margin hardware modules and warrant-related revenue reductions.
Operating income rose to $89.2 million in Q2 and $151.1 million for the first half, while net income increased to $153.1 million in Q2 and $233.4 million year-to-date, supported by a $50.3 million Q2 income tax benefit tied to equity compensation and tax credits. Cash, cash equivalents, and marketable securities totaled $1.3 billion, with $162.3 million of operating cash flow in the first half. The company completed a $74.0 million technology acquisition adding $68.4 million of goodwill and continues to invest heavily in R&D and headcount, while revenue remains concentrated in China, Singapore and Taiwan and among a small number of large customers.
Astera Labs, Inc. reported record preliminary results for the quarter ended June 30, 2026, with revenue of $392.4 million, up 27% sequentially and 104% year-over-year. GAAP gross margin was 73.3%, GAAP operating income was $89.2 million with a 22.7% margin, and GAAP net income reached $153.1 million, or $0.83 per diluted share. On a non-GAAP basis, operating income was $153.5 million with a 39.1% margin, non-GAAP net income was $145.8 million, and non-GAAP diluted EPS was $0.80.
Total assets were $1.93 billion as of June 30, 2026, including $111.5 million of cash and cash equivalents and $1.14 billion of marketable securities, with stockholders’ equity of $1.73 billion. For the first six months of 2026, the company generated $162.3 million of cash from operating activities. For the third quarter of 2026, Astera Labs guides revenue between $540 million and $560 million, GAAP gross margin of approximately 72%, GAAP diluted EPS of $0.87 to $0.92, and non-GAAP diluted EPS of $1.16 to $1.21, supported by ramping Scorpio fabric switches and an expanded AI connectivity portfolio.
BlackRock, Inc. reports beneficial ownership of 12,667,232 shares of Astera Labs Inc. common stock, representing 7.4% of the outstanding class as of June 30, 2026. BlackRock has sole voting power over 11,998,990 shares and sole dispositive power over all 12,667,232 shares.
The position is held across certain reporting business units of BlackRock and its subsidiaries. Various underlying clients have rights to dividends and sale proceeds, but no single client has more than 5% of Astera Labs’ total outstanding common shares.
Cota Germaine reported acquisition or exercise transactions in this Form 4 filing.
Astera Labs, Inc. granted Chief Accounting Officer and VP, Finance Germaine Cota an award of 1,451 restricted stock units of common stock on July 20, 2026 under its 2024 Stock Option and Incentive Plan. Following this award, Cota directly holds 26,440 shares of common stock.
The award provides that 6.25% of the RSUs shall vest in 16 equal quarterly installments after the vesting commencement date of August 15, 2026, conditioned on a continuous service relationship with the company. Each RSU represents a contingent right to receive one share of common stock.